Press Releases
Women take centre stage at ground breaking healthcare conference
Over 50% of the speakers are prominent females in the scientific healthcare field at the ‘World Research and Innovation Congress – Pioneers in Healthcare’ event, Steigenberger Grandhotel, Brussels, 5 and 6 June, 2013. Despite...
Press Releases
BioAlliance Pharma’s Sitavig® Receives Market Authorization in the US For the Treatment of Herpes Labialis
BioAlliance Pharma SA today announced the receipt of marketing authorization from the U.S. Food and Drug Administration (FDA) for Sitavig® in the treatment of recurring Herpes labialis marking the successful conclusion to the assessment procedure carried out by...
Press Releases
Eyevensys announces an equity investment by Boehringer Ingelheim Venture Fund
Eyevensys, a developer of a new process for non-viral gene therapy using electrotransfer that enables prolonged production of therapeutic proteins for the treatment of ocular disease, today announces an equity investment by the Boehringer Ingelheim Venture Fund (BIVF). ...
Press Releases
GE Healthcare Launches its First “Next-Generation” Sequencing Assay
GE Healthcare announced today that Clarient Diagnostic Services Inc. a GE Healthcare company will begin offering a next-generation sequencing assay focused on solid tumor targets for use in clinical trials. This assay will empower researchers to perform prospective...
Press Releases
Oncodesign and OSEO, winners of the IMODI project from the French Government’s Investing for the Future program, announce funding of EUR 13.4 million
In the presence of French president, Francois Hollande, Francois Drouin, OSEO's CEO and vice-president of the BPI (Banque Publique d'Investissement), announced to Philippe Genne, Oncodesign's CEO and leader of the IMODI (Innovative MODels Initiative), that this project will...
Press Releases
Quintiles Digital Properties Win Two Web Marketing Association Awards
Quintiles has received further recognition for the company’s market-leading digital communications with two “Internet Advertising Competition” (IAC) awards: one for its corporate website Quintiles.com and one for its patient education site ClinicalResearch.com. The IAC...
Press Releases
Eyevensys appoints Dr Ivan Cohen-Tanugi as CEO
Eyevensys, a company developing a new non-viral gene therapy process to treat ocular illnesses that enables prolonged production of all therapeutic proteins through electrotransfer, today announces the appointment of Dr Ivan Cohen-Tanugi as CEO. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read